Navigation Links
AMT CEO Ronald Lorijn Steps Down
Date:1/22/2009

has in-depth knowledge of gene therapy and of the company as he is CSO and co-founder of AMT. The Supervisory Board is pleased that he will be the CEO ad interim until a successor is found. We are confident that under his leadership the company will make great progress."

The Supervisory Board will begin a search for a new CEO immediately.

The Company plans to report its annual results 2008 on February 24, 2009. AMT expects results to be in line with the guidance given earlier.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with nine products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Ac
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
2. MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors
3. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
4. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
5. Graphene pioneers follow in Nobel footsteps
6. Pharmaxis First Steps into China
7. Three Steps to Boost Asymchems Investment in China
8. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
9. New White Paper Details Six Steps to Investigate and Prevent Laboratory Accidents
10. Yale scientists make 2 giant steps in advancement of quantum computing
11. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... LEXINGTON, Mass. , Sept. 22, 2014 /PRNewswire/ ... GEVA ), a biopharmaceutical company developing ... appointment of Robert Bazemore as Chief ... Patel , President and Chief Executive Officer, Robert ... the company,s lead program, sebelipase alfa for LAL ...
(Date:9/21/2014)... of Basel in Switzerland have succeeded in observing ... for the first time. These extremely weak spectra ... properties and may also contribute to the development ... were published in the scientific journal Nature ... interaction between matter and light, is probably the ...
(Date:9/21/2014)... Chemical Sciences play a significant ... clean air and safe water, healthy food, and ... environmentalists, food scientists, educators, and scientists have a ... field of Chemistry for the national development, and ... of the fastest emerging Sciences, accelerating with a ...
(Date:9/20/2014)... September 20, 2014 HealthTronics, ... and interventional radiology products and services, has signed ... with Clinicon Corporation for its high ... portfolio of minimally invasive, mobile, surgical technology—offering more ... Under the agreement, HealthTronics will make available Clinicon’s ...
Breaking Biology Technology:Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Uncovering the forbidden side of molecules 2Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3
... Consolidated service revenue of $238.7 million grows 32% year-over-year, - ... - Backlog increases ... - Net quarterly book-to-burn ratio ... PRXL ) today announced its financial results for the,second quarter ...
... of Family Cord Blood Banks, LOS ANGELES, ... of California Cryobank, today announced that its co-founder ... appointed to the Department,of Health and Human Services, ... on Blood Stem Cell Transplantation,(ACBSCT). Through his appointment, ...
... required milestone for functional food partners and ... /PRNewswire-FirstCall/ - Neptune Technologies &,Bioressources Inc. ("Neptune") ... Oil ("NKO(R)") has been determined to be,safe ... status required for the,commercialization of NKO(R) incorporated ...
Cached Biology Technology:PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 3PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 4PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 5PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 6PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 7PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 8PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 9PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 10Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council 2Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council 3Neptune Technologies receives GRAS notification in the United States 2Neptune Technologies receives GRAS notification in the United States 3
(Date:9/21/2014)... team of Stanford researchers has developed a protein therapy ... break away from original tumor sites, travel through the ... the body. , This process, known as metastasis, can ... "The majority of patients who succumb to cancer fall ... Cochran, an associate professor of bioengineering who describes a ...
(Date:9/19/2014)... study multifunctional and specialized spinal cord nerve cells ... Foundation grant in the amount of $680,000 for ... the Department of Biology, OU College of Arts ... the multifunctional and specialized spinal cord nerve cells ... connections they make. Berkowitz will collaborate with ...
(Date:9/19/2014)... A new study shows that legume plants regulate ... cytokininssignaling molecules that are transmitted through the plant ... the number of bacteria-holding nodules in the roots. ... the National Institute for Basic Biology, the Graduate ... Center for Sustainable Resource Science in Japan. ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4For legume plants, a new route from shoot to root 2
... motor excitability have a better working memory than humans with ... by scientists from the Transfacultary Research Platform at the University ... drawn as to the general cortical excitability as well ... temporary storage of information such as memorizing a phone number ...
... found new clues to how plants evolved to withstand wintry ... issue of the journal Nature , the team constructed ... plants the largest time-scaled evolutionary tree to date. By ... stem data for thousands of species, the researchers were able ...
... The Scripps Research Institute (TSRI) have demonstrated a drug-discovery ... of chemical compounds that have a desired effect on ... To illustrate the power of the innovative technique, the ... shows promise for treating obesity-linked diabetes. At the same ...
Cached Biology News:Motor excitability predicts working memory 2Study offers clues to how plants evolved to cope with cold 2Study offers clues to how plants evolved to cope with cold 3Innovative screening strategy swiftly uncovers new drug candidates, new biology 2Innovative screening strategy swiftly uncovers new drug candidates, new biology 3Innovative screening strategy swiftly uncovers new drug candidates, new biology 4
... Molecular Probes is pleased to ... for the ultrasensitive detection of primary ... at Indiana University, the ATTO-TAG reagents ... o-phthaldialdehyde (OPA), naphthalene-2,3-dicarboxaldehyde (NDA) and anthracene-2,3-dicarboxaldehyde, ...
...
Human Cystatin A MAb (Clone 224705)...
Corticoliberin...
Biology Products: